NGS Pancreas Carcinoma

Whole sequencing of BRCAness-associated genes, including BRCA1, BRCA2, PALB2, KRAS, CDK12, and other pathogenic variants from the entire TruSight Oncology 500 HRD assay. Analysis of MSI, TMB, GIS, and fusions (including NRG1) from the Oncomine Comprehensive Assay v3 RNA. To order this analysis, please contact the Customer Service Center: contact@viollier.ch or 0848 121 121.This analysis may result in excess information. This will be communicated, unless it is noted otherwise when placing the order. Since in rare cases there may also be indications of hereditary changes, the GUMG shall ensure the patient is informed accordingly (see www.viollier.ch/en/SGMG_consent). Tarification: according to Tardoc.